Individualisation of Menopausal Hormone Therapy and Its Impact on Long-term Health - European Medical Journal

This site is intended for healthcare professionals

Individualisation of Menopausal Hormone Therapy and Its Impact on Long-term Health

This promotional infographic was sponsored and reviewed by Theramex HQ UK Ltd.

Individualisation of Menopausal Hormone Therapy and Its Impact on Long-term Health Infographic

UK Prescribing information for Bijuva® (oestradiol and progesterone) can be found here. Licensing and availability may vary by country.
For healthcare professionals outside of the UK, please refer to local prescribing information before prescribing and your local Summary of Product Characteristics (SmPC) and regulations to report any adverse events.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google Play or Apple App store.

Adverse events should also be reported to Theramex on [email protected] or Tel: +44 (0)333 0096795

 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.